Pfizer vaccine
Three doses of Pfizer Covid vaccine better than two: Study
During the study period, the predominant variant was Delta and not Omicron
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
Pfizer aims to give children as young as 6 months shots that contain one-tenth of the dose given to adults
Mixing other vaccines with AstraZeneca, Pfizer jabs generates robust immune response
The Lancet study found that no safety concerns were raised in the study of 1,070 participants
Moderna says its low-dose COVID shot works for kids 6 to 11
Moderna hasn't yet gotten the go-ahead to offer its vaccine to teens
COVID-19 pills are no substitute for vaccines, disease experts say
Some disease experts fear the arrival of oral COVID-19 treatments may further impede vaccination campaigns
Pfizer vaccine highly effective against Covid hospitalisations for six months: Study
The study underscores the importance of improving COVID-19 vaccination rates worldwide
FDA backs Pfizer COVID-19 boosters for seniors, high-risk
Under the FDA authorization, vaccinated Americans are eligible for a third dose six months after receiving their second Pfizer shot
80 per cent COVID-19 immunity lost in 6 months in some after Pfizer shot: US study
The research studied blood samples of 120 nursing home residents and 92 health care workers
New Zealand reports first death linked to Pfizer vaccine
The case has been referred to the coroner and the cause of death has not yet been determined
Pfizer, AstraZeneca vaccine antibody levels may drop after 2-3 months: Lancet study
Those vaccinated with AstraZeneca vaccine are likely to have much lower antibody levels than those vaccinated with the Pfizer vaccine